Pharmaguideline.com recives any estimated n/a unique visitors and n/a unique page views per day. Revenue gained from these much visits may be n/a per day from various advertising sources. The estimated worth of site is n/a.
- Website Age
n/a
- Alexa Rank no-data
- Country
United States
- IP Address
172.67.131.128
google ads
HTML SIZE INFORMATION
pharmaguideline.com has a website text/code ratio of 5.91 %. Search engine crawlers tend to not pick up pages with inadequate content.
IMPORTANT HTML TAGS AND COUNTS
Titles
H1
| No |
Text |
| 1 |
Pharmaceutical guidelines |
H2
| No |
Text |
| 1 |
Controlled area in sterile pharmaceutical manufacturing |
| 2 |
Various types of blenders and their purpose |
| 3 |
Possibilities of contamination in sterile products |
| 4 |
Covıd-19 sop for home in 15 different languages |
| 5 |
ımportance of corrective and preventive action (capa) |
| 6 |
Covıd-19 sop for home |
| 7 |
Prevention of microbial contamination in manufacturing |
| 8 |
Critical and non-critical areas in pharmaceutical manufacturing |
| 9 |
Different types of hplc detectors |
| 10 |
Concept of gxp in pharmaceuticals |
| 11 |
Criteria for selection of clean room garments in pharmaceuticals |
| 12 |
Best weighing practices in pharmaceuticals |
| 13 |
Requirement of alarm system in critical equipments |
| 14 |
Protective gears used in pharmaceutical sterile areas |
| 15 |
Lux and light ıntensity for pharmaceutical areas |
| 16 |
About the author |
| 17 |
Pop****r categories |
| 18 |
Follow pharmaguideline |
| 19 |
Doc***ents |
| 20 |
Discussion - latest topics |
| 21 |
Get app for news updates |
Text Styling
- STRONG0
- B7
- EM0
- I2
- U0
- CITE0
B
| No |
Text |
| 1 |
Download and Print COVID-19 SOP for Home in your preferred language. |
| 2 |
1.0 Objective: |
| 3 |
2.0 Scope: |
| 4 |
3.0 Responsibility: |
| 5 |
4.0 Accountability: |
| 6 |
info@pharmaguideline.com |
| 7 |
Get Free Updates |
I
| No |
Text |
| 1 |
adsbypg |
| 2 |
Pharmaguideline Forum |
LINK ANALYSIS
Total Link Count: 274
Internal Link Count
: 138
| No |
Text |
Type |
| 1 |
Contact Us |
text |
| 2 |
Books |
text |
| 3 |
Disclaimer |
text |
| 4 |
Privacy |
text |
| 5 |
- |
image |
| 6 |
View |
text |
| 7 |
Home |
text |
| 8 |
Quality Control |
text |
| 9 |
Quality a***urance |
text |
| 10 |
Microbiology |
text |
| 11 |
Production |
text |
| 12 |
SOPs |
text |
| 13 |
Validation |
text |
| 14 |
GMP |
text |
| 15 |
Audit |
text |
| 16 |
Doc***ents |
text |
| 17 |
- |
empty |
| 18 |
- |
empty |
| 19 |
Controlled area in Sterile Pharmaceutical Manufacturing |
text |
| 20 |
Production |
text |
| 21 |
Sterile |
text |
| 22 |
No comments |
text |
| 23 |
Full Article |
text |
| 24 |
- |
empty |
| 25 |
Various Types of Blenders and Their Purpose |
text |
| 26 |
Equipment |
text |
| 27 |
GMP |
text |
| 28 |
Production |
text |
| 29 |
No comments |
text |
| 30 |
Full Article |
text |
| 31 |
- |
empty |
| 32 |
Possibilities of Contamination in Sterile Products |
text |
| 33 |
GMP |
text |
| 34 |
Production |
text |
| 35 |
Sterile |
text |
| 36 |
1 comment |
text |
| 37 |
Full Article |
text |
| 38 |
- |
empty |
| 39 |
COVID-19 SOP for Home in 15 Different Languages |
text |
| 40 |
SOP |
text |
| 41 |
No comments |
text |
| 42 |
Full Article |
text |
| 43 |
- |
empty |
| 44 |
Importance of Corrective and Preventive Action (CAPA) |
text |
| 45 |
GMP |
text |
| 46 |
Quality a***urance |
text |
| 47 |
1 comment |
text |
| 48 |
Full Article |
text |
| 49 |
- |
empty |
| 50 |
COVID-19 SOP for Home |
text |
External Link Count
: 136
| No |
Text |
Type |
| 1 |
Forum |
text |
| 2 |
Store |
text |
| 3 |
Videos |
text |
| 4 |
Research |
text |
| 5 |
Advertise |
text |
| 6 |
Affiliate |
text |
| 7 |
App |
text |
| 8 |
- |
empty |
| 9 |
- |
empty |
| 10 |
- |
empty |
| 11 |
- |
empty |
| 12 |
- |
empty |
| 13 |
- |
empty |
| 14 |
Join |
text |
| 15 |
Log In |
text |
| 16 |
Ask Question |
text |
| 17 |
- |
empty |
| 18 |
- |
empty |
| 19 |
- |
empty |
| 20 |
- |
empty |
| 21 |
Share |
text |
| 22 |
Tweet |
text |
| 23 |
Share |
text |
| 24 |
- |
empty |
| 25 |
- |
empty |
| 26 |
- |
empty |
| 27 |
- |
empty |
| 28 |
Share |
text |
| 29 |
Tweet |
text |
| 30 |
Share |
text |
| 31 |
- |
empty |
| 32 |
- |
empty |
| 33 |
- |
empty |
| 34 |
- |
empty |
| 35 |
Share |
text |
| 36 |
Tweet |
text |
| 37 |
Share |
text |
| 38 |
- |
empty |
| 39 |
- |
empty |
| 40 |
- |
empty |
| 41 |
- |
empty |
| 42 |
Share |
text |
| 43 |
Tweet |
text |
| 44 |
Share |
text |
| 45 |
- |
empty |
| 46 |
- |
empty |
| 47 |
- |
empty |
| 48 |
- |
empty |
| 49 |
Share |
text |
| 50 |
Tweet |
text |
| 51 |
Share |
text |
| 52 |
- |
empty |
| 53 |
- |
empty |
| 54 |
- |
empty |
| 55 |
- |
empty |
| 56 |
Share |
text |
| 57 |
Tweet |
text |
| 58 |
Share |
text |
| 59 |
- |
empty |
| 60 |
- |
empty |
| 61 |
- |
empty |
| 62 |
- |
empty |
| 63 |
Share |
text |
| 64 |
Tweet |
text |
| 65 |
Share |
text |
| 66 |
- |
empty |
| 67 |
- |
empty |
| 68 |
- |
empty |
| 69 |
- |
empty |
| 70 |
Share |
text |
| 71 |
Tweet |
text |
| 72 |
Share |
text |
| 73 |
- |
empty |
| 74 |
- |
empty |
| 75 |
- |
empty |
| 76 |
- |
empty |
| 77 |
Share |
text |
| 78 |
Tweet |
text |
| 79 |
Share |
text |
| 80 |
- |
empty |
| 81 |
- |
empty |
| 82 |
- |
empty |
| 83 |
- |
empty |
| 84 |
Share |
text |
| 85 |
Tweet |
text |
| 86 |
Share |
text |
| 87 |
- |
empty |
| 88 |
- |
empty |
| 89 |
- |
empty |
| 90 |
- |
empty |
| 91 |
Share |
text |
| 92 |
Tweet |
text |
| 93 |
Share |
text |
| 94 |
- |
empty |
| 95 |
- |
empty |
| 96 |
- |
empty |
| 97 |
- |
empty |
| 98 |
Share |
text |
| 99 |
Tweet |
text |
| 100 |
Share |
text |
| 101 |
- |
empty |
| 102 |
- |
empty |
| 103 |
- |
empty |
| 104 |
- |
empty |
| 105 |
Share |
text |
| 106 |
Tweet |
text |
| 107 |
Share |
text |
| 108 |
- |
empty |
| 109 |
- |
empty |
| 110 |
- |
empty |
| 111 |
- |
empty |
| 112 |
Share |
text |
| 113 |
Tweet |
text |
| 114 |
Share |
text |
| 115 |
- |
empty |
| 116 |
- |
empty |
| 117 |
- |
empty |
| 118 |
- |
empty |
| 119 |
Share |
text |
| 120 |
Tweet |
text |
| 121 |
Share |
text |
| 122 |
Like |
text |
| 123 |
Follow |
text |
| 124 |
Follow |
text |
| 125 |
Follow |
text |
| 126 |
Follow |
text |
| 127 |
Install |
text |
| 128 |
Join |
text |
| 129 |
Show All ❭❭ |
text |
| 130 |
Install |
text |
| 131 |
- |
empty |
| 132 |
- |
empty |
| 133 |
- |
empty |
| 134 |
- |
empty |
| 135 |
- |
empty |
| 136 |
- |
empty |
Nofollow Link Count
: 117
| No |
Text |
Type |
| 1 |
- |
empty |
| 2 |
- |
empty |
| 3 |
- |
empty |
| 4 |
- |
empty |
| 5 |
- |
empty |
| 6 |
- |
empty |
| 7 |
- |
empty |
| 8 |
- |
empty |
| 9 |
- |
empty |
| 10 |
- |
empty |
| 11 |
Share |
text |
| 12 |
Tweet |
text |
| 13 |
Share |
text |
| 14 |
- |
empty |
| 15 |
- |
empty |
| 16 |
- |
empty |
| 17 |
- |
empty |
| 18 |
Share |
text |
| 19 |
Tweet |
text |
| 20 |
Share |
text |
| 21 |
- |
empty |
| 22 |
- |
empty |
| 23 |
- |
empty |
| 24 |
- |
empty |
| 25 |
Share |
text |
| 26 |
Tweet |
text |
| 27 |
Share |
text |
| 28 |
- |
empty |
| 29 |
- |
empty |
| 30 |
- |
empty |
| 31 |
- |
empty |
| 32 |
Share |
text |
| 33 |
Tweet |
text |
| 34 |
Share |
text |
| 35 |
- |
empty |
| 36 |
- |
empty |
| 37 |
- |
empty |
| 38 |
- |
empty |
| 39 |
Share |
text |
| 40 |
Tweet |
text |
| 41 |
Share |
text |
| 42 |
- |
empty |
| 43 |
- |
empty |
| 44 |
- |
empty |
| 45 |
- |
empty |
| 46 |
Share |
text |
| 47 |
Tweet |
text |
| 48 |
Share |
text |
| 49 |
- |
empty |
| 50 |
- |
empty |
| 51 |
- |
empty |
| 52 |
- |
empty |
| 53 |
Share |
text |
| 54 |
Tweet |
text |
| 55 |
Share |
text |
| 56 |
- |
empty |
| 57 |
- |
empty |
| 58 |
- |
empty |
| 59 |
- |
empty |
| 60 |
Share |
text |
| 61 |
Tweet |
text |
| 62 |
Share |
text |
| 63 |
- |
empty |
| 64 |
- |
empty |
| 65 |
- |
empty |
| 66 |
- |
empty |
| 67 |
Share |
text |
| 68 |
Tweet |
text |
| 69 |
Share |
text |
| 70 |
- |
empty |
| 71 |
- |
empty |
| 72 |
- |
empty |
| 73 |
- |
empty |
| 74 |
Share |
text |
| 75 |
Tweet |
text |
| 76 |
Share |
text |
| 77 |
- |
empty |
| 78 |
- |
empty |
| 79 |
- |
empty |
| 80 |
- |
empty |
| 81 |
Share |
text |
| 82 |
Tweet |
text |
| 83 |
Share |
text |
| 84 |
- |
empty |
| 85 |
- |
empty |
| 86 |
- |
empty |
| 87 |
- |
empty |
| 88 |
Share |
text |
| 89 |
Tweet |
text |
| 90 |
Share |
text |
| 91 |
- |
empty |
| 92 |
- |
empty |
| 93 |
- |
empty |
| 94 |
- |
empty |
| 95 |
Share |
text |
| 96 |
Tweet |
text |
| 97 |
Share |
text |
| 98 |
- |
empty |
| 99 |
- |
empty |
| 100 |
- |
empty |
| 101 |
- |
empty |
| 102 |
Share |
text |
| 103 |
Tweet |
text |
| 104 |
Share |
text |
| 105 |
- |
empty |
| 106 |
- |
empty |
| 107 |
- |
empty |
| 108 |
- |
empty |
| 109 |
Share |
text |
| 110 |
Tweet |
text |
| 111 |
Share |
text |
| 112 |
- |
empty |
| 113 |
- |
empty |
| 114 |
- |
empty |
| 115 |
- |
empty |
| 116 |
- |
empty |
| 117 |
- |
empty |
Title Link Count
: 0
WEBSITE SERVER INFORMATION
- Service Provider (ISP)
- Cloudflare, Inc.
- Hosted IP Address
- 172.67.131.128
- Hosted Country
United States
- Host Region
- Illinois , Chicago
- Latitude and Longitude
- 41.8781 : -87.6298
WEBSITES USING THE SAME C CLASS IP